###begin article-title 0
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Development and characterization of IL-21-producing CD4+ T cells
###end article-title 0
###begin p 1
###xml 33 60 33 60 <email xmlns:xlink="http://www.w3.org/1999/xlink">nakajimh@faculty.chiba-u.jp</email>
CORRESPONDENCE Hiroshi Nakajima: nakajimh@faculty.chiba-u.jp
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 277 278 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 411 412 411 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 541 542 541 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 719 720 712 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 782 783 775 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 854 855 847 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1104 1105 1097 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1316 1317 1306 1307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
It has recently been shown that interleukin (IL)-21 is produced by Th17 cells, functions as an autocrine growth factor for Th17 cells, and plays critical roles in autoimmune diseases. In this study, we investigated the differentiation and characteristics of IL-21-producing CD4+ T cells by intracellular staining. Unexpectedly, we found that under Th17-polarizing conditions, the majority of IL-21-producing CD4+ T cells did not produce IL-17A and -17F. We also found that IL-6 and -21 potently induced the development of IL-21-producing CD4+ T cells without the induction of IL-4, IFN-gamma, IL-17A, or IL-17F production. On the other hand, TGF-beta inhibited IL-6- and IL-21-induced development of IL-21-producing CD4+ T cells. IL-2 enhanced the development of IL-21-producing CD4+ T cells under Th17-polarizing conditions. Finally, IL-21-producing CD4+ T cells exhibited a stable phenotype of IL-21 production in the presence of IL-6, but retained the potential to produce IL-4 under Th2-polarizing conditions and IL-17A under Th17-polarizing conditions. These results suggest that IL-21-producing CD4+ T cells exhibit distinct characteristics from Th17 cells and develop preferentially in an IL-6-rich environment devoid of TGF-beta, and that IL-21 functions as an autocrine growth factor for IL-21-producing CD4+ T cells.
###end p 3
###begin p 4
A. Suto and D. Kashiwakuma contributed equally to this work.
###end p 4
###begin p 5
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 267 268 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 269 270 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 359 360 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 361 362 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 481 482 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 483 484 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 631 632 627 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 633 634 629 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
Activated CD4+ T cells differentiate into at least three distinct effector subsets as defined by their patterns of cytokine production (1-4). Th1 cells produce IFN-gamma and lymphotoxin and play a critical role in protective immunity against intracellular pathogens (1-4). Th2 cells produce IL-4, -5, and -13 and are essential for the expulsion of parasites (1-4). Newly identified Th17 cells produce IL-17A and -17F and play a pathogenic role in a variety of autoimmune diseases (1-5). Recently, it has been reported that IL-21 is another cytokine highly produced by Th17 cells and that it promotes the development of Th17 cells (6-9).
###end p 5
###begin p 6
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 619 621 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 774 782 774 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sanroque</italic>
###xml 789 791 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 921 923 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 980 981 980 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
###xml 783 787 <span type="species:ncbi:10090">mice</span>
###xml 873 878 <span type="species:ncbi:10090">mouse</span>
IL-21 is a four-helix-bundle type I cytokine with significant homology to IL-2, -15, and -4 (10-12). IL-21 has been demonstrated to be expressed in Th2 cells (13), follicular B helper T cells (14), and NK T cells (15) and to exhibit pleiotropic effects on the proliferation, differentiation, and effector function of T, B, NK, and dendritic cells (10-12). In vivo, it has been shown that IL-21 is involved in several autoimmune disease models. For example, lymphopenia and compensatory IL-21-mediated homeostatic expansion of lymphocytes has been reported to be involved in the development of autoimmunity in NOD mice (16). The excessive production of IL-21 has been shown to be associated with the development of high titers of autoantibodies and a lupus-like pathology in Sanroque mice (17). Furthermore, a blockade of IL-21 signaling has been demonstrated to ameliorate mouse models of rheumatoid arthritis and lupus (18, 19). However, the characteristic of IL-21-producing CD4+ T cells, especially in their relation to Th17 cells, is still unknown because a single-cell analysis of IL-21-producing cells has not been achieved yet.
###end p 6
###begin p 7
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 223 224 223 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 361 362 361 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 532 533 525 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 622 623 615 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 730 731 723 724 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 760 761 753 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1007 1008 1000 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1091 1092 1084 1085 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1250 1251 1240 1241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
In this study, by establishing the intracellular staining of IL-21, we found that although IL-21-producing CD4+ T cells developed preferentially under Th17-polarizing conditions, a considerable number of IL-21-producing CD4+ T cells were negative for intracellular IL-17A and -17F. We also found that IL-6 potently induced the development of IL-21-producing CD4+ T cells without the induction of IL-4, IFN-gamma, IL-17A, or IL-17F production. On the other hand, TGF-beta inhibited the IL-6-induced development of IL-21-producing CD4+ T cells. In addition, IL-2 significantly enhanced the development of IL-21-producing CD4+ T cells under Th17-polarizing conditions. IL-21 itself also induced the development of IL-21-producing CD4+ T cells. IL-21-producing CD4+ T cells exhibited a stable phenotype of IL-21 production in the presence of IL-6, but still had a potential to produce IL-4 under Th2-polarizing conditions and IL-17A under Th17-polarizing conditions. Our results suggest that IL-21-producing CD4+ T cells exhibit distinct characteristics from Th17 cells, that IL-21-producing CD4+ T cells develop preferentially in an IL-6-rich environment devoid of TGF-beta, and that IL-21 functions as an autocrine growth factor for IL-21-producing CD4+ T cells.
###end p 7
###begin title 8
RESULTS
###end title 8
###begin title 9
###xml 19 20 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
IL-21-producing CD4+ T cells develop preferentially under Th17-polarizing conditions, but the majority of them are negative for intracellular IL-17A and -17F
###end title 9
###begin p 10
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 182 183 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 240 241 240 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 444 452 437 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 616 617 609 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1046 1054 1039 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 1446 1454 1439 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 1526 1534 1519 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 1184 1189 <span type="species:ncbi:10090">mouse</span>
###xml 1197 1202 <span type="species:ncbi:9606">human</span>
###xml 1252 1257 <span type="species:ncbi:9606">human</span>
Recently, it has been shown that Th17 cells produce a large amount of IL-21 compared with Th2 and Th1 cells, and that IL-21 functions as an autocrine growth factor for Th17 cells (6-9). We also found that IL-21 was produced by activated CD4+ T cells under Th17-polarizing conditions (in the presence of IL-6, TGF-beta, anti-IL-4 mAb, and anti-IFN-gamma mAb) much greater than under Th2-polarizing conditions or under Th1-polarizing conditions (Fig. 1 A). However, it was still unclear whether IL-21 is actually produced by Th17 cells and what is the developmental and phenotypic characteristic of IL-21-producing CD4+ T cells because IL-21 production has not been determined at single-cell levels as yet. To address these issues, we established the intracellular cytokine staining of IL-21. We first generated several IL-21-producing Ba/F3 cell clones using a bicistronic retrovirus system and measured the levels of IL-21 in the culture supernatants by ELISA. Among these clones, Ba/F3-IL-21-GFP #6 cells produced a significant amount of IL-21 (Fig. 1 B, left), and we used this clone as a positive control for intracellular staining of IL-21. To detect intracellular IL-21, we used mouse IL-21R/human Fc-chimera (IL-21R-Fc) to capture IL-21 and anti-human Fc PE to visualize IL-21-IL-21R-Fc complexes. When cells were stained by this method, positive signals were detected in Ba/F3-IL-21-GFP #6 cells, but not in control Ba/F3-empty-GFP cells (Fig. 1 B, right). In the absence of IL-21R-Fc, no positive signal was detected (Fig. 1 B, right), confirming the correct detection of IL-21 by the intracellular staining.
###end p 10
###begin p 11
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Establishment of a single-cell analysis of IL-21&#8211;producing cells.</bold>
###xml 114 115 114 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 170 171 170 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 323 324 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
Establishment of a single-cell analysis of IL-21-producing cells. (A) IL-21 and -17A are produced by activated CD4+ T cells under Th17-polarizing conditions. Purified CD4+ T cells from lymph nodes of C57BL/6 mice were stimulated with anti-CD3 mAb/anti-CD28 mAb under Th1-, Th2-, and Th17-polarizing conditions. On day 5, 106 cells were restimulated with anti-CD3 mAb/anti-CD28 mAb for 24 h. The levels of cytokines in the culture supernatants were measured by ELISA. Data are the means +/- the SD from four independent experiments. *, P < 0.01. (B) Establishment of a single-cell analysis of IL-21-producing cells. Ba/F3 cells were infected with pMX-IL-21-IRES-GFP retrovirus or control retrovirus (pMX-IRES-GFP). Nine clones of pMX-IL-21-IRES-GFP retrovirus-infected Ba/F3 cells (Ba/F3-IL-21-GFP cells) and one clone of control retrovirus-infected Ba/F3 cells (Ba/F3-GFP cells) were selected by limiting dilution. IL-21 in the culture supernatants was measured by ELISA (left). Ba/F3-GFP cells and Ba/F3-IL-21-GFP clone #6 cells were fixed, permeabilized, and incubated with IL-21R-Fc or PBS. After washing, cells were visualized with anti-Fc PE (right).
###end p 11
###begin p 12
###xml 77 78 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 136 137 136 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 151 154 151 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 164 165 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 427 433 427 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 517 518 517 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 571 579 571 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 721 722 721 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 769 775 769 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 938 939 938 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 997 1003 997 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1025 1026 1025 1026 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1125 1131 1121 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1189 1190 1185 1186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1291 1292 1287 1288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
By using the intracellular staining of IL-21, we examined IL-21-producing CD4+ T cells at single-cell levels. When FACS-sorted naive CD4+ T cells (CD44low CD25- CD4+ T cells) were stimulated with anti-CD3 mAb/anti-CD28 mAb under Th1-, Th2-, and Th17-polarizing conditions, IL-21-producing cells were detected under Th17-polarizing conditions with a high frequency and under Th2-polarizing conditions with a moderate frequency (Fig. 2), which is consistent with the levels of IL-21 in the supernatants of activated CD4+ T cells under the corresponding culture conditions (Fig. 1 A). Under Th2-polarizing conditions, a significant number of IL-4-producing cells simultaneously produced IL-21 and >70% of IL-21-producing CD4+ T cells were positive for intracellular IL-4 (Fig. 2). Under Th17-polarizing conditions, a significant number of IL-17A- and IL-17F-producing cells also simultaneously produced IL-21, but >60% of IL-21-producing CD4+ T cells were negative for intracellular IL-17A and -17F (Fig. 2). IL-21-producing CD4+ T cells under Th17-polarizing conditions were also negative for intracellular IL-4 and IFN-gamma (Fig. 2). These results suggest that although IL-21-producing CD4+ T cells develop preferentially under Th17-polarizing conditions, the majority of IL-21-producing CD4+ T cells do not produce IL-17A or -17F.
###end p 12
###begin p 13
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 98 0 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD4<sup>+</sup> T cells producing IL-21, but not IL-17A/IL-17F, are present under Th17-polarizing conditions.</bold>
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
CD4+ T cells producing IL-21, but not IL-17A/IL-17F, are present under Th17-polarizing conditions. Naive CD4+ T cells from lymph nodes of C57BL/6 mice were stimulated with anti-CD3 mAb/anti-CD28 mAb under Th1-, Th2-, and Th17-polarizing conditions for 5 d. Cells were evaluated for the expression of the indicated cytokines by intracellular cytokine staining as described in the Materials and methods. Data are representative of three independent experiments.
###end p 13
###begin title 14
###xml 75 76 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
IL-6 induces, but TGF-beta inhibits, the development of IL-21-producing CD4+ T cells
###end title 14
###begin p 15
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 147 155 147 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 160 166 160 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 257 258 254 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 277 278 274 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 558 559 544 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 640 648 622 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 735 736 714 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 773 781 752 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 896 904 872 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 969 970 942 943 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1078 1080 1051 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 1081 1083 1054 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 1182 1190 1152 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 1272 1273 1242 1243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1369 1370 1336 1337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Because IL-21-producing CD4+ T cells developed preferentially under Th17-polarizing conditions as compared with Th1- or Th2-polarizing conditions (Fig. 1 A and Fig. 2), we next examined the role of IL-6 and TGF-beta in the development of IL-21-producing CD4+ T cells. Naive CD4+ T cells were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of IL-6, anti-IL-4 mAb, and anti-IFN-gamma mAb with or without TGF-beta. We found that IL-6 together with the blocking antibodies to IL-4 and IFN-gamma strongly induced the development of IL-21-producing CD4+ T cells without the induction of IL-4, IFN-gamma, IL-17A, or IL-17F production (Fig. 3 A). Furthermore, unexpectedly, TGF-beta inhibited the development of IL-21-producing CD4+ T cells in a dose-dependent manner (Fig. 3 A). Measurement of IL-21 levels in the supernatants confirmed the TGF-beta-mediated inhibition of IL-21 production (Fig. 3 B). TGF-beta also inhibited the development of IL-21-producing CD4+ T cells under Th2-polarizing conditions (unpublished data). In contrast, consistent with previous reports (20-22), TGF-beta together with IL-6 induced the development of IL-17A- and IL-17F-producing Th17 cells (Fig. 3 A). These results indicate that IL-6 induces the development of IL-21-producing CD4+ T cells, but on the contrary, TGF-beta inhibits IL-6-induced development of IL-21-producing CD4+ T cells.
###end p 15
###begin p 16
###xml 75 76 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 85 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IL-6 induces, but TGF-&#946; inhibits, the development of IL-21&#8211;producing CD4<sup>+</sup> T cells.</bold>
###xml 105 106 102 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 644 645 632 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 758 759 744 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
IL-6 induces, but TGF-beta inhibits, the development of IL-21-producing CD4+ T cells. (A and B) Naive CD4+ T cells from C57BL/6 mice were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of 10 mug/ml anti-IL-4 mAb and 10 mug/ml anti-IFN-gamma mAb (neutral condition) with or without 100 ng/ml IL-6. Where indicated, 0.2-2 ng/ml TGF-beta was added. (A) 4 d later, cells were stimulated with PMA/ionomycin, and intracellular staining for the indicated cytokines was performed. Shown are representative FACS profiles from three independent experiments. (B) 4 d later, cells were washed and stimulated with PMA/ionomycin for 8 h at 2 x 106 cells/ml. The levels of IL-21 in the culture supernatants were measured by ELISA. Data are the mean +/- the SD (n = 3). *, P < 0.05; **, P < 0.01.
###end p 16
###begin p 17
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 223 224 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 339 340 335 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 445 451 441 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 507 508 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 586 587 582 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 626 632 622 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 674 675 670 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 741 747 737 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 770 771 766 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 870 876 866 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
We next examined the kinetics of IL-21, -17A, and -17F production from naive CD4+ T cells upon stimulation with anti-CD3 mAb/anti-CD28 mAb. In the presence of IL-6, anti-IL-4 mAb, and anti-IFN-gamma mAb, IL-21-producing CD4+ T cells were detected at a low frequency at day 1 after stimulation, and then the frequency of IL-21-producing CD4+ T cells was increased until day 4 in a time-dependent manner without the production of IL-17A and -17F (Fig. 4). Under Th17-polarizing conditions, IL-21-producing CD4+ T cells were also detected at day 1, but the frequency of IL-21-producing CD4+ T cells was not increased thereafter (Fig. 4). On the other hand, IL-17A-producing CD4+ T cells were detected at day 2 under Th17-polarizing conditions (Fig. 4). IL-17F-producing CD4+ T cells were also detected at day 2 under Th17-polarizing conditions and were increased at day 4 (Fig. 4).
###end p 17
###begin p 18
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Kinetics of IL-21 production from CD4<sup>+</sup> T cells.</bold>
###xml 57 58 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Kinetics of IL-21 production from CD4+ T cells. Naive CD4+ T cells from C57BL/6 mice were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of anti-IL-4 mAb and anti-IFN-gamma mAb (neutral condition) with 100 ng/ml IL-6 or IL-6 plus 1 ng/ml TGF-beta. At indicated times after stimulation, cells were stimulated with PMA/ionomycin, and intracellular staining for the indicated cytokines was performed. Shown are representative FACS profiles from three independent experiments.
###end p 18
###begin title 19
###xml 72 73 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Smad3 is involved in TGF-beta-mediated inhibition of IL-21-producing CD4+ T cells
###end title 19
###begin p 20
###xml 87 89 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 91 93 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 207 209 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 211 213 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 258 261 255 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 367 368 361 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 390 391 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 434 437 428 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 481 482 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 584 586 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 782 783 769 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 860 866 847 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 991 992 972 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1022 1025 1003 1006 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1029 1030 1010 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1211 1212 1189 1190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 1076 1080 <span type="species:ncbi:10090">mice</span>
Smad2 and Smad3 are phosphorylated by TGF-beta receptor and heterodimerize with Smad4 (23, 24). The activated Smad complex then translocates into the nucleus and regulates the transcription of target genes (23, 24). We then used the mice lacking Smad3 (Smad3-/- mice) to determine whether Smad3 is required for the TGF-beta-mediated suppression of IL-21-producing CD4+ T cells. Purified CD4+ T cells from WT mice or asymptomatic Smad3-/- mice, in the latter of which lymph node CD4+ T cells exhibit a normal phenotype regarding the activation markers such as CD69 (unpublished data) (25), were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of IL-6, anti-IL-4 mAb, anti-IFN-gamma mAb, and anti-IL-2 mAb with or without TGF-beta and the development of IL-21-producing CD4+ T cells and Th17 cells was evaluated by intracellular staining. As shown in Fig. 5, not only TGF-beta-mediated induction of Th17 cell development but also TGF-beta-mediated suppression of IL-21-producing CD4+ T cells were reduced in Smad3-/- CD4+ T cells compared with those in littermate WT mice. These results indicate that TGF-beta signaling induces Th17 cell development, but inhibits the development of IL-21-producing CD4+ T cells, in part via Smad3-dependent pathways.
###end p 20
###begin p 21
###xml 79 80 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 89 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Smad3 is involved in TGF-&#946;&#8211;mediated suppression of IL-21 production from CD4<sup>+</sup> T cells.</bold>
###xml 102 103 99 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 122 125 119 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
Smad3 is involved in TGF-beta-mediated suppression of IL-21 production from CD4+ T cells. Purified CD4+ T cells from Smad3-/- mice or littermate WT mice were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of anti-IL-4 mAb, anti-IFN-gamma mAb, and anti-IL-2 mAb with 100 ng/ml IL-6 or IL-6 plus 1 or 5 ng/ml TGF-beta for 3 d. Cells were then stimulated with PMA/ionomycin and intracellular staining for IL-21 versus IL-17A was performed. Shown are representative FACS profiles from three independent experiments.
###end p 21
###begin title 22
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
IL-2 does not inhibit the development of IL-21-producing CD4+ T cells
###end title 22
###begin p 23
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 180 181 180 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 205 206 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 419 420 415 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 430 436 426 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 558 559 554 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 569 575 565 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 623 624 619 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 726 732 722 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 894 895 890 891 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 905 907 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 1065 1066 1061 1062 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
It has recently been reported that IL-2 signaling via STAT5 inhibits the development of Th17 cells (26). We next examined the role of IL-2 in the development of IL-21-producing CD4+ T cells. When naive CD4+ T cells were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of IL-6, anti-IL-4 mAb, and anti-IFN-gamma mAb, neither IL-2 nor anti-IL-2 mAb significantly affected the development of IL-21-producing CD4+ T cells (Fig. 6). On the other hand, under Th17-polarizing conditions, IL-2 significantly enhanced the development of IL-21-producing CD4+ T cells (Fig. 6). In contrast, IL-17A- and IL-17F-producing CD4+ T cells were decreased by IL-2 and were increased by anti-IL-2 mAb under Th17-polarizing conditions (Fig. 6), which is consistent with the previous study showing that the genetic deletion or antibody blockade of IL-2 promotes the differentiation of IL-17A-producing CD4+ T cells (26). These results suggest that, in contrast to the development of Th17 cells, IL-2 instead exerts an enhancing effect on the development of IL-21-producing CD4+ T cells under Th17-polarizing conditions.
###end p 23
###begin p 24
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IL-2 does not inhibit the development of IL-21&#8211;producing CD4<sup>+</sup> T cells.</bold>
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
IL-2 does not inhibit the development of IL-21-producing CD4+ T cells. Naive CD4+ T cells from C57BL/6 mice were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of anti-IL-4 mAb and anti-IFN-gamma mAb with 100 ng/ml IL-6 or IL-6 plus 1 ng/ml TGF-beta. Where indicated, either 10 ng/ml IL-2 or 10 mug/ml anti-IL-2 antibody was added to the culture. 4 d later, cells were stimulated with PMA/ionomycin and intracellular staining for the indicated cytokines was performed. Shown are representative FACS profiles from three independent experiments.
###end p 24
###begin title 25
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
IL-21 functions as an autocrine growth factor for IL-21-producing CD4+ T cells
###end title 25
###begin p 26
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 190 191 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 320 321 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 341 342 337 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 389 392 385 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 397 398 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 408 416 404 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 480 481 476 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 517 525 510 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 563 569 556 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 616 618 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 674 675 667 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 800 808 789 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 901 902 890 891 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
It was recently reported that IL-21 functions as an autocrine growth factor for the development of Th17 cells (6-9). We determined the role of IL-21 on the development of IL-21-producing CD4+ T cells. IL-21, in the presence of the blocking antibodies to IL-4 and IFN-gamma, induced the development of IL-21-producing CD4+ T cells from WT CD4+ T cells, but not from IL-21R-deficient (IL-21R-/-) CD4+ T cells (Fig. 7 A). In addition, IL-21-induced development of IL-21-producing CD4+ T cells was inhibited by TGF-beta (Fig. 7 A), like IL-6-induced development was (Fig. 3). Soluble IL-21R-Fc, which neutralizes IL-21 (10), also inhibited the development of IL-21-producing CD4+ T cells both in the presence of IL-6, anti-IL-4 mAb, and anti-IFN-gamma mAb and under Th17-polarizing conditions by 20-30% (Fig. 7 B). These results suggest that IL-21 and -6 both induce the development of IL-21-producing CD4+ T cells, the effect of the latter of which is mediated in part by IL-21 production.
###end p 26
###begin p 27
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IL-21 induces the development of IL-21&#8211;producing CD4<sup>+</sup> T cells.</bold>
###xml 76 77 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 97 100 97 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 534 535 527 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 959 960 944 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 556 560 <span type="species:ncbi:10090">mice</span>
###xml 982 986 <span type="species:ncbi:10090">mice</span>
IL-21 induces the development of IL-21-producing CD4+ T cells. (A) Naive CD4+ T cells from IL-21R-/- mice or littermate WT mice on a BALB/c background were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of anti-IL-4 mAb and anti-IFN-gamma mAb (neutral condition) with 100 ng/ml IL-21 or 1 ng/ml IL-21 plus TGF-beta. 4 d later, cells were stimulated with PMA/ionomycin and intracellular staining for IL-21 versus IL-17A was performed. Shown are representative FACS profiles from three independent experiments. (B) Naive CD4+ T cells from BALB/c mice were stimulated with anti-CD3 mAb/anti-CD28 mAb for 4 d in the presence of anti-IL-4 mAb and anti-IFN-gamma mAb with IL-6 or IL-6 plus TGF-beta. Where indicated, soluble IL-21R-Fc (10 mug/ml) was added. Cells were stimulated with PMA/ionomycin and intracellular staining for IL-21 versus IL-17A was performed. Shown are representative FACS profiles from three independent experiments. (C) Naive CD4+ T cells from C57BL/6 mice were stimulated with anti-CD3 mAb/anti-CD28 mAb under Th2-polarizing conditions for 5 d. Where indicated, a neutralizing antibody against 10 mug/ml IL-6 and/or soluble IL-21R-Fc were added. Cells were then stimulated with PMA/ionomycin and intracellular staining for the indicated cytokines was performed. Shown are representative FACS profiles from three independent experiments.
###end p 27
###begin p 28
###xml 119 127 119 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 254 255 254 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 345 351 345 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
In contrast, the blockade of IL-21 signaling by soluble IL-21R-Fc resulted in the decreased development of Th17 cells (Fig. 7 B), which is consistent with previous reports (6-9). Together with our finding that a considerable number of IL-21-producing CD4+ T cells are negative for intracellular IL-17A and -17F under Th17-polarizing conditions (Fig. 2), these results suggest that IL-21 functions not only as an autocrine growth factor but also as a paracrine growth factor for the development of Th17 cells.
###end p 28
###begin p 29
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 119 120 119 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 183 191 183 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 C</xref>
###xml 273 274 273 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 474 475 474 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 646 647 646 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 739 747 739 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 C</xref>
###xml 888 889 888 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 928 929 928 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
We also examined the effect of anti-IL-6 antibody on the differentiation of IL-21-producing CD4+ T cells from naive CD4+ T cells cultured under Th2-polarizing conditions. As shown in Fig. 7 C, a neutralizing antibody against IL-6 decreased the number of IL-21-producing CD4+ T cells by 50% without any significant change in the number of IL-4 single-positive cells. Moreover, although soluble IL-21R-Fc itself did not significantly decrease the number of IL-21-producing CD4+ T cells under Th2-polarizing conditions (unpublished data), IL-21R-Fc together with anti-IL-6 antibody significantly suppressed the differentiation of IL-21-producing CD4+ T cells under Th2-polarizing conditions to a greater extent than anti-IL-6 antibody alone (Fig. 7 C). These results suggest that during Th2 cell differentiation, IL-6 produced by Th2 cells promotes the differentiation of IL-21-producing CD4+ T cells from Th2 cells and non-Th2 CD4+ T cells.
###end p 29
###begin title 30
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Expression of transcription factors in CD4+ T cells cultured in the presence of IL-6
###end title 30
###begin p 31
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 198 199 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 205 206 201 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 310 316 302 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 335 336 327 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 490 496 474 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 614 620 598 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
We also examined the expression pattern of transcription factors in CD4+ T cells that were cultured in the presence of IL-6, anti-IL-4 mAb, and anti-IFN-gamma mAb. Consistent with previous reports (5), CD4+ T cells cultured under Th17-polarizing conditions expressed RORgammat, but not Foxp3, T-bet, or GATA3 (Fig. 8). In contrast, CD4+ T cells cultured in the presence of IL-6, anti-IL-4 mAb, and anti-IFN-gamma mAb expressed a moderate level of RORgammat, but not Foxp3, T-bet, or GATA3 (Fig. 8). As expected, Th1 cells expressed T-bet, Th2 cells expressed GATA3, and regulatory T (T reg) cells expressed Foxp3 (Fig. 8).
###end p 31
###begin p 32
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of transcription factors in CD4<sup>+</sup> T cells cultured in the presence of IL-6.</bold>
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 308 309 298 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
Expression of transcription factors in CD4+ T cells cultured in the presence of IL-6. Naive CD4+ T cells from C57BL/6 mice were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of anti-IL-4 mAb and anti-IFN-gamma mAb with IL-6, IL-6 plus TGF-beta, or TGF-beta alone for 60 h. As controls, naive CD4+ T cells were stimulated with anti-CD3 mAb/anti-CD28 mAb under Th1-polarizing conditions or Th2-polarizing conditions for 60 h. The expression of RORgammat, Foxp3, T-bet, and GATA3 was assessed by real-time PCR. Data are representative of three independent experiments.
###end p 32
###begin title 33
The frequency of IL-21-producing cells is increased with the rounds of cell cycle progression
###end title 33
###begin p 34
###xml 97 98 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 223 224 223 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 275 281 275 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9</xref>
###xml 342 343 342 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 481 482 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 709 715 701 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9</xref>
###xml 941 947 933 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9</xref>
It has been shown that the production of cytokines such as IL-4 is correlatively increased in CD4+ T cells with cell divisions (27, 28). We next examined the correlation of IL-21 production and cell cycle progression of CD4+ T cells using a CFSE-labeling method. As shown in Fig. 9, the frequency of cell division was indistinguishable in CD4+ T cells cultured in the presence of IL-6, anti-IL-4 mAb, and anti-IFN-gamma mAb and under Th17-polarizing conditions. IL-21-producing CD4+ T cells were observed in all rounds of cell cycle progression in the presence of IL-6, anti-IL-4 mAb, and anti-IFN-gamma mAb, but the frequency of IL-21-producing cells was increased with the rounds of cell cycle progression (Fig. 9). Similarly, under Th17-polarizing conditions, IL-17A- and IL-17F-producing cells were observed in all rounds of cell cycle progression, but the frequency of them was also increased with the rounds of cell cycle progression (Fig. 9).
###end p 34
###begin p 35
###xml 0 94 0 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The frequency of IL-21&#8211;producing cells is increased with the rounds of cell cycle progression.</bold>
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
The frequency of IL-21-producing cells is increased with the rounds of cell cycle progression. Naive CD4+ T cells from C57BL/6 mice were labeled with CFSE, stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of anti-IL-4 mAb and anti-IFN-gamma mAb (neutral condition) with IL-6 or IL-6 plus TGF-beta for 4 d. Cells were stimulated with PMA/ionomycin and intracellular staining for IL-21, -17A, and -17F was performed. Shown are representative FACS profiles from three independent experiments.
###end p 35
###begin title 36
###xml 19 20 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
IL-21-producing CD4+ T cells do not lose the ability to produce IL-21 when they are restimulated under Th1- or Th2-polarizing conditions
###end title 36
###begin p 37
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 175 176 175 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 261 262 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 519 528 515 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 A</xref>
###xml 555 556 551 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 733 734 725 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 849 850 841 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 937 938 929 930 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1166 1175 1154 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 A</xref>
###xml 1205 1206 1193 1194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1340 1341 1324 1325 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1424 1425 1408 1409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1548 1557 1532 1541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 A</xref>
###xml 1595 1596 1579 1580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1671 1672 1655 1656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1752 1753 1736 1737 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1820 1829 1804 1813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 A</xref>
###xml 1867 1868 1851 1852 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2003 2004 1987 1988 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Fully differentiated Th1 cells and Th2 cells exhibit a stable phenotype regarding the pattern of cytokine production (29, 30). Finally, we examined whether IL-21-producing CD4+ T cells exhibited a stable phenotype of IL-21 production. To address this issue, CD4+ T cells were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of IL-6, anti-IL-4 mAb, and anti-IFN-gamma mAb twice, at a 5-d interval, and IL-21 production was assessed by intracellular staining after restimulation with anti-CD3 mAb. As shown in Fig. 10 A (top), IL-21-producing CD4+ T cells did not lose their ability to produce IL-21 at 10 d and did not produce a significant amount of IFN-gamma, IL-4, or IL-17A. This stable phenotype of IL-21-producing CD4+ T cells was observed at least for 20 d of culture (unpublished data). We also examined whether IL-21-producing CD4+ T cells exhibited a stable phenotype against Th1, Th2, or Th17 polarization. After CD4+ T cells were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of IL-6, anti-IL-4 mAb, and anti-IFN-gamma mAb for 5 d, these cells were restimulated under Th1-, Th2-, or Th17-polarizing conditions for 5 d. As shown in Fig. 10 A (bottom), IL-21-producing CD4+ T cells that were restimulated under Th1-polarizing conditions produced IL-21, but not IFN-gamma, indicating that IL-21-producing CD4+ T cells are stable against Th1 polarization. In contrast, when IL-21-producing CD4+ T cells were restimulated under Th2-polarizing conditions, a considerable population of cells produced both IL-21 and -4 (Fig. 10 A), suggesting that IL-21-producing CD4+ T cells may have a potential for IL-4 production. When IL-21-producing CD4+ T cells were restimulated under Th17-polarizing conditions, IL-21-producing CD4+ T cells were decreased and IL-17A-producing cells were increased (Fig. 10 A), suggesting that IL-21-producing CD4+ T cells may also have a potential for the differentiation of Th17 cells. Collectively, these results indicate that IL-21-producing CD4+ T cells exhibit a stable phenotype of IL-21 production in the presence of IL-6, but may still have a potential for IL-4 and -17A production.
###end p 37
###begin p 38
###xml 19 20 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 139 0 139 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IL-21&#8211;producing CD4<sup>+</sup> T cells do not lose their ability to produce IL-21 when they are restimulated under Th1- or Th2-polarizing conditions.</bold>
###xml 156 157 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 654 655 650 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
IL-21-producing CD4+ T cells do not lose their ability to produce IL-21 when they are restimulated under Th1- or Th2-polarizing conditions. (A) Purified CD4+ T cells from C57BL/6 mice were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of anti-IL-4 mAb and anti-IFN-gamma mAb with IL-6 for 5 d. Cells were restimulated for another 5 d under the same condition (top) or Th1-, Th2-, or Th17-polarizing conditions (bottom). On day 10, cells were stimulated with anti-CD3 mAb and intracellular staining for indicated cytokines was performed. Shown are representative FACS profiles from three independent experiments. (B) As positive controls, CD4+ T cells from C57BL/6 mice were stimulated with anti-CD3 mAb/anti-CD28 mAb under Th1-, Th2-, or Th17-polarizing conditions for 5 d. Cells were restimulated under the same conditions for another 5 d. On day 10, cells were stimulated with anti-CD3 mAb and intracellular staining for indicated cytokines was performed.
###end p 38
###begin title 39
DISCUSSION
###end title 39
###begin p 40
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 202 203 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 315 316 315 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 374 380 374 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 462 463 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 545 551 541 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 637 638 630 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 675 681 668 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 731 733 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 734 736 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 806 812 796 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 879 880 869 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 900 901 890 891 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 930 933 920 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 937 938 927 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 948 954 938 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 1018 1019 1008 1009 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1055 1061 1042 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 1099 1105 1086 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 1120 1121 1107 1108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1236 1242 1219 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 1299 1306 1282 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10</xref>
###xml 1369 1370 1352 1353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1453 1454 1436 1437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1612 1613 1592 1593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
In this study, we investigated the differentiation and characteristics of IL-21-producing CD4+ T cells. By the newly developed intracellular staining of IL-21, we found that although IL-21-producing CD4+ T cells developed preferentially under Th17-polarizing conditions, a considerable number of IL-21-producing CD4+ T cells were negative for intracellular IL-17A and -17F (Fig. 2). We also found that IL-6 strongly induced the development of IL-21-producing CD4+ T cells without the induction of IL-4, IFN-gamma, IL-17A, and IL-17F production (Fig. 3). Furthermore, TGF-beta inhibited the IL-6-induced development of IL-21-producing CD4+ T cells in a dose-dependent manner (Fig. 3). In contrast, consistent with previous reports (20-22), TGF-beta together with IL-6 induced the development of Th17 cells (Fig. 3). IL-21 itself also induced the development of IL-21-producing CD4+ T cells from WT CD4+ T cells, but not from IL-21R-/- CD4+ T cells (Fig. 7). In addition, IL-21-induced development of IL-21-producing CD4+ T cells was inhibited by TGF-beta (Fig. 7), like IL-6-induced development was (Fig. 3). Finally, CD4+ T cells cultured in the presence of IL-6 expressed a moderate level of RORgammat, but not Foxp3, T-bet, or GATA3 (Fig. 8), and exhibited a stable phenotype of IL-21 production (Fig. 10). Collectively, these results suggest that IL-21-producing CD4+ T cells exhibit distinct characteristics from Th17 cells, that IL-21-producing CD4+ T cells develop preferentially in an IL-6-rich environment devoid of TGF-beta, and that IL-21 functions as an autocrine growth factor for IL-21-producing CD4+ T cells.
###end p 40
###begin p 41
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 124 125 124 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 358 359 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 448 449 448 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 688 689 688 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 779 786 779 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Figs. 2</xref>
###xml 791 792 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">3</xref>
###xml 869 870 869 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
IL-21 was originally reported to be a product of activated CD4+ T cells (10). Subsequently, it has been shown that among CD4+ T cells, Th2 cells but not Th1 cells produce IL-21 (13). More recently, it has been demonstrated that Th17 cells produce higher levels of IL-21 than Th2 cells and that IL-21 functions as an autocrine growth factor for Th17 cells (6-9). However, all of these findings were based on the analysis on a mixed population of CD4+ T cells because there has been no single-cell analysis for IL-21 production available as yet. In this study, we have established the intracellular cytokine staining of IL-21 and have shown that a considerable number of IL-21-producing CD4+ T cells under Th17-polarizing conditions are negative for intracellular IL-17A and -17F (Figs. 2 and 3), providing a new insight into the cellular source of IL-21 in activated CD4+ T cells.
###end p 41
###begin p 42
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 96 103 96 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Figs. 3</xref>
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">7</xref>
###xml 172 173 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 277 278 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 361 367 361 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 463 464 463 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 592 593 592 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 661 669 661 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 672 673 672 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 674 675 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 734 735 734 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 811 818 811 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Figs. 2</xref>
###xml 823 824 823 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">3</xref>
We show that IL-6 and -21 both potently induce the development of IL-21-producing CD4+ T cells (Figs. 3 and 7). In addition, IL-6-induced development of IL-21-producing CD4+ T cells is mediated in part by IL-21 production because IL-6-induced development of IL-21-producing CD4+ T cells was modestly, but reproducibly, decreased by the neutralization of IL-21 (Fig. 7). In a preliminary study, we also found that IL-21 enhanced the survival of IL-21-producing CD4+ T cells (unpublished data). These results suggest that IL-21 may function as an autocrine growth factor for IL-21-producing CD4+ T cells. In contrast, because IL-21 induces Th17 cell development (Fig. 7 A) (6-9), and because a considerable number of IL-21-producing CD4+ T cells under Th17-polarizing conditions are negative for IL-17A and -17F (Figs. 2 and 3), it is suggested that IL-21 functions on Th17 cells not only as an autocrine growth factor but also as a paracrine growth factor.
###end p 42
###begin p 43
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 200 207 200 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Figs. 3</xref>
###xml 212 213 212 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">7</xref>
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 318 319 315 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 329 336 326 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Figs. 3</xref>
###xml 338 339 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">4</xref>
###xml 345 346 342 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">7</xref>
###xml 433 439 427 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 442 444 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 445 447 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 585 587 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 589 591 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 692 693 683 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 703 709 694 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 778 779 769 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Our results indicate that the developmental characteristic of IL-21-producing CD4+ T cells is different from that of Th17 cells, although both T cells require IL-6 and/or IL-21 for their development (Figs. 3 and 7) (6-9). We demonstrate that TGF-beta inhibits IL-6- and IL-21-induced development of IL-21-producing CD4+ T cells (Figs. 3, 4, and 7). In contrast, both IL-6 and TGF-beta are required for the development of Th17 cells (Fig. 3) (20-22). On the other hand, it has been shown that TGF-beta induces, but IL-6 inhibits, the development of Foxp3-expressing regulatory T cells (20, 31). In addition, IL-2 signaling inhibits the development of Th17 cells, but not of IL-21-producing CD4+ T cells (Fig. 6). These findings suggest that the development of IL-21-producing CD4+ T cells, Th17 cells, and T reg cells is reciprocally regulated by the balance among IL-6 plus IL-21, TGF-beta, and IL-2 in an environment.
###end p 43
###begin p 44
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 239 240 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 250 257 250 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Figs. 3</xref>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">7</xref>
###xml 432 433 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 435 436 431 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 515 516 511 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 618 620 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 668 670 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 853 855 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 857 859 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 916 918 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 919 921 912 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 984 985 974 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 995 1001 985 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
Molecular mechanisms underlying the development of IL-21-producing CD4+ T cells remain to be elucidated. We show that IL-6 and -21, both of which use STAT3 as a signaling molecule (11, 12, 32), induce the development of IL-21-producing CD4+ T cells (Figs. 3 and 7). It has also been reported that under Th17-polarizing conditions, IL-21 production is induced by a STAT3-dependent mechanism, but not a RORgammat-dependent mechanism (6, 7), suggesting that STAT3 is critical for the development of IL-21-producing CD4+ T cells. Because IL-6 up-regulates NFAT transcriptional activity by increasing the levels of NFATc2 (33), and because NFATc2 activates IL-21 promoter (34), it is also plausible that IL-6-mediated activation of NFATc2 is involved in the induction of IL-21 gene expression. Because Foxp3, which is induced by TGF-beta-mediated signaling (31, 35), interacts with NFAT and down-regulates NFAT activity (36-38), TGF-beta may suppress the development of IL-21-producing CD4+ T cells (Fig. 3) by producing Foxp3-NFATc2 complexes.
###end p 44
###begin p 45
###xml 58 59 58 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 308 310 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 394 400 388 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 403 405 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 407 409 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 480 481 474 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 743 744 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 784 785 778 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 671 675 <span type="species:ncbi:10090">mice</span>
Recently, it has been shown that IL-22 is expressed in CD4+ T cells under Th17-polarizing conditions (6, 39, 40) and that it mediates IL-23-induced dermal inflammation and hyperplasia of the epidermis in psoriasis (40). Interestingly, similar to IL-21, IL-22 is induced by IL-6 but is inhibited by TGF-beta (40). In contrast, IL-17A and -17F are expressed in the presence of IL-6 and TGF-beta (Fig. 3) (41, 42). However, at present, it is still unknown whether IL-21-producing CD4+ T cells do produce IL-22 together. The detailed analysis of autoimmune disease models in IL-21-deficient mice, IL-17A/IL-17F double-deficient mice, and IL-17A/IL-17F/IL-21 triple-deficient mice may provide evidence for a nonredundant role of IL-21-producing CD4+ T cells and IL-17A/IL-17F-producing CD4+ T cells in the pathogenesis of autoimmune diseases.
###end p 45
###begin p 46
###xml 57 58 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 101 102 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 161 168 161 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10</xref>
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 354 361 354 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10</xref>
###xml 398 399 398 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 470 471 470 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 558 559 558 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 623 624 619 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 684 691 680 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10</xref>
###xml 741 742 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1002 1004 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 1044 1045 1032 1033 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1194 1201 1182 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10</xref>
###xml 1234 1235 1222 1223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Regarding the phenotypic stability of IL-21-producing CD4+ T cells, we found that IL-21-producing CD4+ T cells could produce IL-21 for at least 20 d of culture (Fig. 10 and not depicted). We also found that IL-21-producing CD4+ T cells did not lose their ability to produce IL-21 even when they were restimulated under Th1- or Th2-polarizing conditions (Fig. 10). Interestingly, IL-21-producing CD4+ T cells still had a potential to produce IL-4 when IL-21-producing CD4+ T cells were restimulated under Th2-polarizing conditions, whereas IL-21-producing CD4+ T cells did not produce IFN-gamma even when IL-21-producing CD4+ T cells were restimulated under Th1-polarizing conditions (Fig. 10). These results indicate that IL-21-producing CD4+ T cells exhibit a stable phenotype of IL-21 production and the silencing of IFN-gamma production. This is consistent with our previous finding that IL-21 inhibits IFN-gamma production in developing Th1 cells through the repression of Eomesodermin expression (43). In contrast, when IL-21-producing CD4+ T cells were restimulated under Th17-polarizing conditions, their ability to produce IL-21 was decreased and IL-17A-producing cells were increased (Fig. 10). Therefore, IL-21-producing CD4+ T cells still have a potential for IL-4 and -17A production.
###end p 46
###begin p 47
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 188 189 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 413 414 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 601 602 601 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
It has recently been shown that a subset of CD4+ T cells, termed follicular B helper T cells (TFH cells), produce a large amount of IL-21 (14). TFH cells are distinguishable from other CD4+ T cell populations by several criteria, including its location in B cell follicles and the expression of chemokine receptor CXCR5, and provide a helper function to B cells (14). In preliminary experiments, we found that CD4+ T cells cultured in the presence of IL-6 were negative for CXCR5 expression (unpublished data). Therefore, although further studies are required, it is suggested that IL-21-producing CD4+ T cells described in the present study seem to be different from TFH cells. The comparative analysis of their helper function to B cells, as well as the regulatory mechanism of IL-21 production, is required to further address the relationship between these populations.
###end p 47
###begin p 48
###xml 84 87 81 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 91 92 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 129 130 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 140 146 137 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 230 233 224 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 237 238 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 248 254 242 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 423 424 414 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 521 524 509 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 528 529 516 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 539 545 527 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 644 647 629 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 651 652 636 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 662 664 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 743 745 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 747 749 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 815 818 797 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 822 823 804 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
We found that TGF-beta-mediated suppression of IL-21 production was reduced in Smad3-/- CD4+ T cells compared with that in WT CD4+ T cells (Fig. 5). We also found that TGF-beta-mediated induction of Th17 cells was reduced in Smad3-/- CD4+ T cells (Fig. 5). These results indicate that TGF-beta-Smad3 signaling is involved not only in the induction of Th17 cell development but also in the suppression of IL-21-producing CD4+ T cells. Interestingly, however, the inhibitory effects of TGF-beta were still observed in Smad3-/- CD4+ T cells (Fig. 5). This is consistent with a previous study showing that TGF-beta exhibits partial effects on Smad3-/- CD4+ T cells (44). Because the molecular functions of Smad3 are somewhat overlapping to Smad2 (23, 24), it is suggested that TGF-beta exhibits partial effects on Smad3-/- CD4+ T cells by using Smad2 as a partner of Smad4.
###end p 48
###begin p 49
###xml 111 112 111 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 172 173 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 344 345 341 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
In conclusion, we have shown that IL-6 and -21 preferentially induce the differentiation of IL-21-producing CD4+ T cells and that the differentiation of IL-21-producing CD4+ T cells and Th17 cells is differently regulated by TGF-beta and IL-2. Although further studies are required to address the physiological importance of IL-21-producing CD4+ T cells in vivo, our results should add a new insight into the regulatory mechanism of helper T cell differentiation and the pathogenesis of autoimmune diseases.
###end p 49
###begin title 50
MATERIALS AND METHODS
###end title 50
###begin title 51
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 51
###begin p 52
###xml 101 104 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 148 151 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
BALB/c mice and C57BL/6 mice were purchased from Charles River Laboratories. IL-21R-deficient (IL-21R-/-) mice (45) on a BALB/c background and Smad3-/- mice (46) on a C57BL/6 background (provided by S. Honjo, M. Fujimoto, K. Kobayashi, and A. Sakamoto, Chiba University, Chiba, Japan) were described previously. All mice were housed in microisolator cages under specific pathogen-free conditions and animal procedures used in this study were approved by the Chiba University Animal Care and Use Committee.
###end p 52
###begin title 53
Reagents.
###end title 53
###begin p 54
###xml 159 165 <span type="species:ncbi:10090">Murine</span>
###xml 219 224 <span type="species:ncbi:9606">Human</span>
###xml 235 241 <span type="species:ncbi:10090">murine</span>
###xml 249 255 <span type="species:ncbi:10090">murine</span>
Antibodies to CD3 (145-2C11), CD25 (PC61), CD28 (37.51), CD44 (IM7), IL-4 (11B11), IL-6 (MP5-20F3), and IFN-gamma (XMG1.2) were purchased from BD Biosciences. Murine IL-2, -4, -6, and -12 were purchased from PeproTech. Human TGF-beta, murine IL-21, murine IL-23, IL-21R-Fc chimera, and anti-IL-2 antibody (JES6-1A12) were purchased from R&D Systems.
###end p 54
###begin title 55
Cell isolation.
###end title 55
###begin p 56
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 142 143 142 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 201 202 201 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 300 301 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 369 372 369 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 377 378 377 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 469 477 469 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 479 485 479 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 491 498 491 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10</xref>
###xml 503 504 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 572 573 572 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 753 756 753 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 761 762 761 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 766 767 766 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 782 783 782 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 563 568 <span type="species:ncbi:10090">mouse</span>
CD44low CD25- CD4+ naive T cells were isolated from lymph nodes of mice, as previously described (40), with minor modifications. In brief, CD4+ T cells were collected from lymph nodes of mice using CD4+ T cell isolation kit according to the manufacturer's instructions (Miltenyi Biotec). Purified CD4+ T cells were stained with anti-CD44 mAb and anti-CD25 mAb, and CD44low CD25- cells were sorted on a FACSAria cell sorter (BD Biosciences). In the experiments shown in Fig. 1 A, Fig. 5, and Fig. 10, CD4+ T cells were purified from lymph nodes of mice by EasySep mouse CD4+ T cell enrichment kit (StemCell Technologies, Inc.) using an automated cell separator RoboSep (StemCell Technologies, Inc.). In both cases, the resultant cells were >98% pure CD44low CD25- CD4+ T cells or CD4+ T cells, respectively, by FACS analysis.
###end p 56
###begin title 57
Cell culture.
###end title 57
###begin p 58
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 108 109 107 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
Naive CD4+ T cells or purified CD4+ T cells were stimulated with 1 mug/ml plate-bound anti-CD3 mAb at 0.5-106 cells/ml in the presence of 1 mug/ml anti-CD28 mAb in a 48-well plate. Where indicated, cells were cultured under either Th1-polarizing conditions (10 ng/ml IL-2, 1 ng/ml IL-12, and 10 mug/ml anti-IL-4 mAb), Th2-polarizing conditions (10 ng/ml IL-2 and -4 and 10 mug/ml anti-IFN-gamma mAb), or Th17-polarizing conditions (100 ng/ml IL-6, and 1 ng/ml TGF-beta, anti-IL-4 mAb, and anti-IFN-gamma mAb). When cells were cultured for >4 d, 20 ng/ml IL-23 was added under Th17-polarizing conditions. Where indicated, 100 ng/ml IL-6, 0.2-5 ng/ml TGF-beta, 10 ng/ml IL-2, 100 ng/ml IL-21, 10 mug/ml anti-IL-2 mAb, 10 mug/ml anti-IL-6 mAb, or 10 mug/ml IL-21R-Fc was added to the culture.
###end p 58
###begin title 59
Retrovirus transduction.
###end title 59
###begin p 60
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
Bicistronic retrovirus vector pMX-IRES-GFP was a gift from T. Kitamura (Tokyo University, Tokyo, Japan). The IL-21 cDNA was amplified by PCR and cloned into pMX-IRES-GFP (IL-21-IRES-GFP). The production of retroviruses and infection to Ba/F3 cells were performed as previously described (43).
###end p 60
###begin title 61
Intracellular cytokine analysis for IL-21.
###end title 61
###begin p 62
###xml 833 834 805 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1122 1124 1086 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 461 465 <span type="species:ncbi:9925">goat</span>
###xml 471 476 <span type="species:ncbi:9606">human</span>
Cultured cells were washed and restimulated with 20 ng/ml PMA (Calbiochem) plus 1 mug/ml ionomycin (Calbiochem) or plate-bound anti-CD3 mAb at 37degreesC for 5 h in the presence of 2 muM monensin (Sigma-Aldrich). Cells were fixed, permeabilized with Perm/Wash buffer (BD Biosciences), and incubated with IL-21R/Fc chimera for 30 min at 4degreesC. Cells were then washed with Perm/Wash buffer and stained with PE-conjugated affinity-purified F(ab')2 fragment of goat anti-human Fcgamma antibody (anti-Fc PE; Jackson ImmunoResearch Laboratories) for 30 min at 4degreesC. Cells were washed twice and stained with anti-CD4 FITC and anti-IL-4 allophycocyanin (BD Biosciences), anti-IFN-gamma allophycocyanin (BD Biosciences), anti-IL-17A Alexa Fluor 647 (eBioscience), or anti-IL-17F Alexa Fluor 647 (eBioscience). Cytokine profile on CD4+ cells was analyzed on a FACSCalibur using CellQuest Pro software (BD Biosciences). Intracellular cytokine staining for IL-4 versus IFN-gamma was performed using anti-IL-4 PE (BVD4-1D11; BD Biosciences) and anti-IFN-gamma allophycocyanin (XMG1.2, BD Biosciences) as previously described (43).
###end p 62
###begin title 63
Real-time PCR analysis.
###end title 63
###begin p 64
###xml 272 273 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 275 276 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 278 280 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 282 284 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
Total cellular RNA was extracted with TRIzol solution (Invitrogen). Reverse transcription was performed using an iScript cDNA synthesis kit (BioRad Laboratories). Primers and TaqMan probes for T-bet, GATA3, RORgammat, Foxp3, and beta-actin have been previously described (5, 6, 41, 43). Quantitative PCR was performed with an ABI PRISM 7300 sequence detection system (Applied Biosystems). The levels of T-bet, GATA3, RORgammat, or Foxp3 mRNA were normalized to the levels of beta-actin mRNA.
###end p 64
###begin title 65
ELISA.
###end title 65
###begin p 66
The amount of IL-4 and IFN-gamma in the culture supernatant was measured by ELISA kits from BD Bioscience. The amount of IL-17A and -21 in the culture supernatant was measured by ELISA kits from R&D Systems. The assays were performed in duplicate according to the manufacturer's instruction. The minimum significant values of these assays were 8 pg/ml of IL-4, 30 pg/ml of IFN-gamma, 17 pg/ml of IL-17A, and 63 pg/ml of IL-21.
###end p 66
###begin title 67
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
CFSE-labeling of CD4+ T cells.
###end title 67
###begin p 68
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Naive CD4+ T cells were labeled with 1 muM CFSE (Invitrogen) for 10 min at 37degreesC according to the manufacturer's instruction.
###end p 68
###begin title 69
Data analysis.
###end title 69
###begin p 70
###xml 124 125 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Data are summarized as the mean +/- the SD. The statistical analysis of the results was performed by the unpaired Student's t test. P values <0.05 were considered significant.
###end p 70
###begin p 71
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
We thank Dr. T. Kitamura for pMX-IRES-GFP vector; Drs. S. Honjo, M. Fujimoto, K. Kobayashi, and A. Sakamoto for Smad3-/- mice; and Ms. K. Sugaya for technical help.
###end p 71
###begin p 72
This work was supported in part by the grants from the Ministry of Education, Culture, Sports, Science and Technology, the Japanese Government (19790681), Abbott Japan Allergy Research Award, the Naito Foundation, and Mitsubishi Pharma Research Foundation.
###end p 72
###begin p 73
The authors have no conflicting financial interests.
###end p 73

